AstraZeneca gets CDSCO approval for Tremelimumab combination in India
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.